Quantcha now offering unlimited commission-free options trading. Quantchabot has detected a promising Synthetic Long Stock trade opportunity for BRAINSTORM CELL THERAPEUTICS I (BCLI) for the 18-Dec-2020 expiration period. You can analyze the opportunity in depth over at the Quantcha Options Search Engine. BCLI was recently trading at $12.80 and has an implied volatility of 167.59% for this period. Based on an analysis of the options available for BCLI expiring on 18-Dec-2020, there is a 68.27% likelihood that the underlying will close within the analyzed range of $4.26-$38.51 at expiration. In this scenario, the average linear return for the trade would be 52.53%. Upside potential: This synthetic long position offers the same potential benefits and liabilities as a long stock position, but at a discount due to the significant premium at-the-money puts are trading at over calls. In this case, the long call position is opened at a strike of $12.50, which is already $0.30 in the money. An out-of-the-money put at the same strike is sold to finance the call, resulting in a net credit of $1.00 per share. The final position can be considered as having a discount of $1.30 per share over the underlying price of $12.80 for a 10.16% total. Downside risk: This discount is generally a sign of the stock facing considerable short pressure, and may indicate that the stock has become hard to borrow. However, if you have a long view of the underlying over this period, it could be a good opportunity to benefit from the upside at a major discount. To analyze this trade in depth, please visit the Quantcha Options Search Engine.